Home > Insider Trading > Filing (0001209191-17-026471)

Filing Details

Accession Number:: 0001209191-17-026471
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-04-10 21:43:03
Reporting Period:: 2017-04-06

Filing Date:: 2017-04-10
Accepted Time:: 2017-04-10 21:43:03
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1625101	Pulse Biosciences Inc.	PLSE	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1055919	W Robert Duggan	611 S. Fort Harrison Ave., Suite 306 Clearwater FL 33756		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2017-04-06	21,200	$18.54	2,408,686	No	4	P	Direct
Common Stock	Acquisiton	2017-04-06	44,200	$19.70	2,452,886	No	4	P	Direct
Common Stock	Acquisiton	2017-04-07	94,100	$19.59	2,546,986	No	4	P	Direct
Common Stock	Acquisiton	2017-04-10	9,200	$20.38	2,556,186	No	4	P	Direct
Common Stock	Acquisiton	2017-04-10	22,764	$21.40	2,578,950	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Footnotes

This is the weighted average purchase price of the shares, which ranged from $18.122 to $18.79 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
Includes 9,000 shares purchased by the Reporting Person that were inadvertently omitted from previous reports.
This is the weighted average purchase price of the shares, which ranged from $19.125 to $19.976 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
This is the weighted average purchase price of the shares, which ranged from $19.079 to $20.00 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
This is the weighted average purchase price of the shares, which ranged from $20.05 to $20.50 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
This is the weighted average purchase price of the shares, which ranged from $21.13 to $21.616 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.